Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors

In English

Författare

  • Zafira Castaño
  • Timothy Marsh
  • Ramya Tadipatri
  • Hanna S Kuznetsov
  • Fatima Al-Shahrour
  • Mahnaz Paktinat
  • April Greene-Colozzi
  • Björn Nilsson
  • Andrea L Richardson
  • Sandra S McAllister

Summary, in English

The causes for malignant progression of disseminated tumors and the reasons recurrence rates differ in women with different breast cancer subtypes are unknown. Here, we report novel mechanisms of tumor plasticity that are mandated by microenvironmental factors and show that recurrence rates are not strictly due to cell-intrinsic properties. Specifically, outgrowth of the same population of incipient tumors is accelerated in mice with triple-negative breast cancer (TNBC) relative to those with luminal breast cancer. Systemic signals provided by overt TNBCs cause the formation of a tumor-supportive microenvironment enriched for EGF and insulin-like growth factor-I (IGF-I) at distant indolent tumor sites. Bioavailability of EGF and IGF-I enhances the expression of transcription factors associated with pluripotency, proliferation, and epithelial-mesenchymal transition. Combinatorial therapy with EGF receptor and IGF-I receptor inhibitors prevents malignant progression. These results suggest that plasticity and recurrence rates can be dictated by host systemic factors and offer novel therapeutic potential for patients with TNBC.

Avdelning/ar

Publiceringsår

2013-08

Språk

Engelska

Sidor

922-935

Publikation/Tidskrift/Serie

Cancer Discovery

Volym

3

Issue

8

Dokumenttyp

Artikel i tidskrift

Förlag

American Association for Cancer Research

Ämne

  • Cancer and Oncology

Nyckelord

  • Animals
  • Antineoplastic Agents
  • Cell Line, Tumor
  • Cell Proliferation
  • Disease Progression
  • Epidermal Growth Factor
  • Epithelial-Mesenchymal Transition
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Insulin-Like Growth Factor I
  • Mice
  • Mice, Nude
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Neoplasm Transplantation
  • Receptor, Epidermal Growth Factor
  • Receptor, IGF Type 1
  • Stromal Cells
  • Transcription Factors
  • Triple Negative Breast Neoplasms
  • Tumor Microenvironment
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

Status

Published

Forskningsgrupp

  • Hematogenomics

ISBN/ISSN/Övrigt

  • ISSN: 2159-8274